Alexion Pharmaceuticals Files Form 10-Q for Third Quarter 2016

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Alexion Pharmaceuticals Files Form 10-Q for Third Quarter 2016

Alexion Pharma (ALXN) a High Conviction Idea at Citi as 10-Q Overhang Removed

January 5, 2017 9:04 AM EST

Citi analyst Robyn Karnauskas called Alexion Pharma (NASDAQ: ALXN) a 2017 high conviction 'Buy' idea after the 10-Q overhang was lifted with no restatement.

She expects: 1) no restatement & 2) maintaining 2016 guidance will be considered positive by the street.

"We see 2017 guidance... More